切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2024, Vol. 14 ›› Issue (05) : 453 -458. doi: 10.3877/cma.j.issn.2095-2015.2024.05.014

论著

糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究
邱岭1, 朱旭丽2, 浦坚1,(), 邢苗苗1, 吴佳玲1   
  1. 1. 214000 江苏省,无锡市锡山人民医院肾内科
    2. 016200 内蒙古自治区,鄂托克前旗人民医院
  • 收稿日期:2024-02-15 出版日期:2024-10-01
  • 通信作者: 浦坚

Correlation between ecological characteristics of intestinal flora and gastrointestinal dysfunction in patients with diabetic nephropathy

Ling Qiu1, Xuli Zhu2, Jian Pu1,(), Miaomiao Xing1, Jialing Wu1   

  1. 1. Department of Nephrology, Wuxi Xishan People's Hospital, Wuxi 214000, China
    2. Etok Front Banner People's Hospital, Etoke Front Banner, Inner Mongolia 016200, China
  • Received:2024-02-15 Published:2024-10-01
  • Corresponding author: Jian Pu
引用本文:

邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.

Ling Qiu, Xuli Zhu, Jian Pu, Miaomiao Xing, Jialing Wu. Correlation between ecological characteristics of intestinal flora and gastrointestinal dysfunction in patients with diabetic nephropathy[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 453-458.

目的

分析糖尿病肾病(DKD)患者肠道菌群生态特点,并探究肠道菌群生态特点与患者胃肠道功能障碍的关联性。

方法

选取无锡市锡山人民医院2021年3月至2023年3月收治的150例DKD患者,纳入DKD组,并选取同期2型糖尿病(T2DM)患者80例,纳入T2DM组。采集患者新鲜粪便样本,行16sRNA检测,比较2组肠道菌群组成、丰度和多样性差异。按照DKD组患者胃肠道功能障碍症状是否存在,将其分别纳入有功能障碍组、无功能障碍组,对比2亚组患者肠道菌群特点,分析DKD及胃肠道功能障碍与肠道菌群生态特点的关联。

结果

α多样性分析提示,DKD组Chao指数明显高于T2DM组,Shannon指数明显低于T2DM组,差异均有统计学意义(P<0.05)。β多样性主成分分析提示,DKD组、T2DM组肠道菌群结构存在差异性(P<0.05)。门水平上,DKD组厚壁菌门相对丰度较低,变形菌门相对丰度较高;在属水平上,DKD组在大肠志贺菌属相对丰度增加,布劳特菌属、拟杆菌相对丰度降低。150例DKD患者中,103例(68.67%)合并胃肠道功能障碍症状。在厚壁菌门相对丰度水平方面比较,有功能障碍组低于T2DM组和无功能障碍组。在变形菌门相对丰度水平方面,有功能障碍组高于T2DM组和无功能障碍组(P<0.01)。有功能障碍组在厚壁菌门与超敏C反应蛋白、白介素-6呈现正相关,而变形菌门与超敏C反应蛋白、白介素-6呈现负相关(P<0.05)。

结论

DKD患者致病性菌群多样性和丰度增加、有益菌多样性和丰度减少。DKD患者发生胃肠道功能障碍可能与厚壁菌门相对丰度降低,变形菌门相对丰度升高有关。

Objective

To analyze the ecological characteristics of intestinal flora in patients with diabetes nephropathy (DKD), and explore the correlation between the ecological characteristics of intestinal flora and gastrointestinal dysfunction.

Methods

A total of 150 patients with DKD admitted to Wuxi Xishan People's Hospital from March 2021 to March 2023 were selected and included in the DKD group, and 80 patients with type 2 diabetes mellitus (T2DM) were selected and included in the T2DM group. Fresh fecal samples were collected from patients, 16sRNA detection was performed, and the differences in gut microbiota composition, abundance, and diversity were compared between the two groups. According to the presence or absence of gastrointestinal dysfunction symptoms in DKD group patients, they were separately included in the functional impairment group and the non impairment functional group. The characteristics of gut microbiota in the two subgroups were compared, and the association between DKD and gastrointestinal dysfunction and the ecological characteristics of gut microbiota was analyzed.

Results

The α diversity analysis results indicated that the Chao index of the DKD group was significantly higher than that of the T2DM group, and the Shannon index was significantly lower than that of the T2DM group, with statistically significant difference (P<0.05). The β diversity principal component analysis showed that there were differences in the gut microbiota structure between the DKD group and the T2DM group (P<0.05). At the phylum level, the relative abundance of Firmicutes in the DKD group was lower, while the relative abundance of Proteobacteria was higher. At the genus level, the relative abundance of Escherichia Shigella in the DKD group increased, while the relative abundance of Blautia and Bacteroides decreased. Among 150 DKD patients, 103 (68.67%) had gastrointestinal dysfunction symptoms. In terms of relative abundance levels of Firmicutes, the functional impairment group was lower than the T2DM group and the non functional impairment group. In terms of the relative abundance level of Proteobacteria, the functional impairment group was higher than the T2DM group and the non functional impairment group, with statistically significant differences (P<0.01). Firmicutes in the functional impairment group was positive correlated with hypersensitive C-reactive protein and interleukin-6, while Proteobacteria was negatively correlated with hypersensitive C-reactive protein and interleukin-6 (P<0.05).

Conclusion

The diversity and abundance of pathogenic bacteria in patients with diabetes nephropathy are increased, while the diversity and abundance of beneficial bacteria are decreased. Gastrointestinal dysfunction in patients with diabetes nephropathy may be related to the decrease of the relative abundance of Firmicutes and the increase of the relative abundance of Proteobacteria.

表1 两组患者临床资料比较
图1 肠道菌群α多样性分析结果
图2 肠道菌群β多样性分析结果
图3 肠道菌群差异分析
图4 糖尿病肾病组患者有无胃肠道功能障碍的肠道菌群门水平分布
图5 2型糖尿病组、有胃肠道功能组、无胃肠道功能组在不同门丰度水平比较
表2 有功能障碍组患者肠道菌群生态特点与炎症指标的相关性
[1]
Cai K, Ma Y, Cai F, et al. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury[J]. Endocrine, 2022, 76(2): 294-303.
[2]
Bao N, Ding T, Gao Y, et al. Diversity of Intestinal Flora in Elderly Patients with Type 2 Diabetes Mellitus with Early Nephropathy[J]. J Clin Nurs Res, 2023, 7(6): 167-171.
[3]
李雷, 张帆, 方飞, 等. 糖尿病肾病患者肠道菌群分布变化与炎症指标相关性分析[J]. 中华内分泌外科杂志, 2020, 14(6): 507-510.
[4]
Du X, Liu J, Xue Y, et al. Alteration of gut microbial profile in patients with diabetic nephropathy[J]. Endocrine, 2021, 73(1): 71-84.
[5]
Lang R, Wang XH, Li AF, et al. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: A prospective randomized controlled trial[J]. Chron Dis Transl Med, 2020, 6(2): 124-133.
[6]
郭世强, 刘春林, 吴清念. 糖尿病肾病患者肠道菌群及炎症因子变化的临床意义[J]. 中国当代医药, 2022, 29(21): 23-26.
[7]
Wang F, Liu C, Ren LZ, et al. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway[J]. Pharm Biol, 2023, 61(1): 427-436.
[8]
Shi R, Tao Y, Tang H, et al. Abelmoschus Manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non‐obese diabetes mice[J]. Microb Biotechnol, 2023, 16(4): 813-826.
[9]
Shi X, Li Z, Lin W, et al. Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy[J]. Am J Nephrol, 2023, 54(11-12): 451-470.
[10]
姚碧晴, 陈铖. 肠道菌群失调与糖尿病肾病的关系[J]. 中华实用诊断与治疗杂志, 2020, 34(1): 102-105.
[11]
冯春念, 曾琳智, 王仕均, 等. 2型糖尿病与糖尿病肾病患者微炎症及肠道微生物多样性分析[J]. 中国微生态学杂志, 2020, 32(11): 1273-1278.
[12]
Meng X, Ma J, Kang SY, et al. Jowiseungki decoction affects diabetic nephropathy in mice through renal injury inhibition as evidenced by network pharmacology and gut microbiota analyses[J]. Chin Med, 2020, 15(1): 1-19.
[13]
Xu X, Wang H, Guo D, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy[J]. Ren Fail, 2021, 43(1): 1063-1075.
[14]
褚欢, 李雷. 老年2型糖尿病早期肾病患者肠道菌群多样性[J]. 中国微生态学杂志, 2021, 33(8): 916-919.
[15]
Pan L, Han P, Ma S, et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia[J]. Acta Pharm Sin B, 2020, 10(2): 249-261.
[16]
冯真真, 钱磊, 赵琳, 等. 2型糖尿病和糖尿病肾病患者肠道菌群失衡模式及功能变化的研究[J]. 胃肠病学和肝病学杂志, 2022, 31(2): 203-207.
[17]
Rizk FH, El Saadany AA, Atef MM, et al. Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy: Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis[J]. Pflugers Arch, 2023, 475(10): 1161-1176.
[18]
Yu W, Shang J, Guo R, et al. The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy [J]. Ren Fail, 2020, 42(1): 1100-1110.
[1] 费扬, 赵晗希, 孙丽琴, 楼琴华, 胡骏程. 银杏叶提取物对糖尿病肾病患者的疗效及其对尿液外泌体miR-342-3p的干预研究[J]. 中华危重症医学杂志(电子版), 2024, 17(03): 219-224.
[2] 李嘉兴, 孙乙文, 李文星. NLRP3炎性小体在急性胰腺炎中作用的研究进展[J]. 中华普通外科学文献(电子版), 2024, 18(04): 300-304.
[3] 中华医学会器官移植学分会, 中国医疗保健国际交流促进会肾脏移植学分会. 中国胰肾联合移植临床诊疗指南[J]. 中华移植杂志(电子版), 2024, 18(03): 129-147.
[4] 方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 509-513.
[5] 胡欣欣, 孟晓凡, 郭兆安. 高血压肾病的发病机制研究进展[J]. 中华肾病研究电子杂志, 2023, 12(06): 339-343.
[6] 王宁, 刘彦哲, 吴紫莺, 曾超, 雷光华, 沙婷婷, 王伊伦. 基于孟德尔随机化研究探讨肠道菌群与肌少症表型的因果关联[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 333-342.
[7] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[8] 谢鸿, 李娜, 李尚日, 谢涛. 肠道菌群特征对结肠癌化学治疗疗效的影响[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 53-56.
[9] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[10] 白璐, 李青霞, 冯一卓, 刘雪倩, 刘若琪, 曲卓敏, 赵凌霞. 丁酸盐治疗糖尿病肾病的研究进展[J]. 中华临床医师杂志(电子版), 2024, 18(03): 303-308.
[11] 谭莹, 朱鹏飞, 李楠, 黄莉吉, 周希乔, 严倩华, 余江毅. 火把花根片联合黄葵胶囊治疗高或极高进展风险糖尿病肾病的临床探索[J]. 中华临床医师杂志(电子版), 2024, 18(02): 171-177.
[12] 韦美菊, 潘玲. 肠道菌群-胆汁酸代谢轴在慢性肾脏病中的研究进展[J]. 中华临床医师杂志(电子版), 2024, 18(02): 219-222.
[13] 黄莉吉, 王婷, 朱鹏飞, 刘敬顺, 余江毅, 谢绍锋. 芪葵颗粒联合火把花根片对G3A3期糖尿病肾病的疗效及对血清miRNA-21的影响[J]. 中华临床医师杂志(电子版), 2023, 17(12): 1247-1252.
[14] 邬秋俊, 向茜. 甘油三酯-葡萄糖指数与2型糖尿病微血管并发症相关性的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(10): 1109-1112.
[15] 张大涯, 陈世锔, 陈润祥, 张晓冬, 李达, 白飞虎. 肠道微生物群对代谢相关脂肪性肝病发展的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 828-833.
阅读次数
全文


摘要